Nitric oxide (NO) has been
implicated as an important signalling molecule in the
contraction-mediated glucose uptake pathway and may represent
a novel strategy for blood glucose control. The
current study sought to determine whether acute infusion of
the NO donor, sodium nitroprusside (SNP), increases leg
glucose uptake at rest in patients with type 2 diabetes.